Finance

Lists
1801:HKG
Innovent Biologics Inc
89,05 HK$
+1,48%
(+1,30) 1D
16 қаз., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1801...
Open
91,25 HK$
High
92,45 HK$
Low
88,00 HK$
Mkt. cap
155,56 млрд
Avg. vol.
9,91 млн
Volume
9,69 млн
P/E ratio
111,08
52-wk high
112,70 HK$
52-wk low
69,55 HK$
EPS
0,80 HK$
No. of employees
9 мың
Open
91,25 HK$
High
92,45 HK$
Low
88,00 HK$
Mkt. cap
155,56 млрд
Avg. vol.
9,91 млн
Volume
9,69 млн
P/E ratio
111,08
52-wk high
112,70 HK$
52-wk low
69,55 HK$
EPS
0,80 HK$
No. of employees
9 мың
News stories
From web sources and news partners
Profile
Innovent Biologics, Inc. is a publicly listed Chinese biopharmaceutical company that is headquartered in Suzhou, Jiangsu. Wikipedia
About Innovent Biologics Inc
CEOMichael Yu
Employees8,75 мың
Founded2011 ж. 28 қар.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
3,54 млрд
3,54 млрд
4,31 млрд
4,31 млрд
Cost of goods sold
845,12 млн
845,12 млн
999,35 млн
999,35 млн
Cost of revenue
845,12 млн
845,12 млн
999,35 млн
999,35 млн
Research and development expenses
807,71 млн
807,71 млн
841,85 млн
841,85 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,91 млрд
1,91 млрд
1,86 млрд
1,86 млрд
Operating expense
2,72 млрд
2,72 млрд
2,71 млрд
2,71 млрд
Total operating expenses
3,56 млрд
3,56 млрд
3,71 млрд
3,71 млрд
Operating income
-19,96 млн
-19,96 млн
602,76 млн
602,76 млн
Other non operating income
45,19 млн
45,19 млн
31,56 млн
31,56 млн
EBT including unusual items
-29,10 млн
-29,10 млн
805,83 млн
805,83 млн
EBT excluding unusual items
-1,59 млн
-1,59 млн
738,07 млн
738,07 млн
Income tax expense
-18,72 млн
-18,72 млн
179,26 млн
179,26 млн
Effective tax rate
64,33%
64,33%
22,25%
22,25%
Other operating expenses
-
-
-
-
Net income
-10,38 млн
-10,38 млн
626,57 млн
626,57 млн
Net profit margin
-0,29%
-0,29%
14,54%
14,54%
Earnings per share
-
-
-
-
Interest and investment income
124,16 млн
124,16 млн
178,13 млн
178,13 млн
Interest expense
-9,17 млн
-9,17 млн
-20,46 млн
-20,46 млн
Net interest expenses
114,99 млн
114,99 млн
157,67 млн
157,67 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
140,29 млн
140,29 млн
761,42 млн
761,42 млн
Gain or loss from assets sale
-71,00 мың
-71,00 мың
1,36 млн
1,36 млн
AI content may include mistakes. Learn more
Google қолданбалары